title: Therapeutic opportunities: telomere maintenance in inducible pluripotent stem cells.
abstract: It has been demonstrated that exogenous expression of a combination of transcription factors can reprogram differentiated cells such as fibroblasts and keratinocytes into what have been termed induced pluripotent stem (iPS) cells. These iPS cells are capable of differentiating into all the tissue lineages when placed in the right environment and, in the case of mouse cells, can generate chimeric mice and be transmitted through the germline. Safer and more efficient methods of reprogramming are rapidly being developed. Clearly, iPS cells present a number of exciting possibilities, including disease modeling and therapy. A major question is whether the nuclei of iPS cells are truly rejuvenated or whether they might retain some of the marks of aging from the cells from which they were derived. One measure of cellular aging is the telomere. In this regard, recent studies have demonstrated that telomeres in iPS cells may be rejuvenated. They are not only elongated by reactivated telomerase but they are also epigenetically modified to be similar but not identical to embryonic stem cells. Upon differentiation, the derivative cells turn down telomerase, the telomeres begin to shorten again, and the telomeres and the genome are returned to an epigenetic state that is similar to normal differentiated somatic cells. While these preliminary telomere findings are promising, the overall genomic integrity of reprogrammed cells may still be problematic and further studies are needed to examine the safety and feasibility of using iPS cells in regenerative medicine applications.
authors: Department of Microbiology, University of Iowa, IA, USA.
authors: Francoise A
authors: FA
authors: Gourronc
authors: Aloysius J
authors: AJ
authors: Klingelhutz
references: PLoS One. 2009 Dec 02;4(12):e8124
references: 19956585
references: Nature. 2009 Jul 2;460(7251):53-9
references: 19483674
references: Mol Cell. 2009 Aug 28;35(4):403-13
references: 19716786
references: Genes Dev. 2009 Sep 15;23(18):2134-9
references: 19696146
references: Am J Hum Genet. 2009 Dec;85(6):823-32
references: 19944403
references: Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5856-61
references: 18391196
references: Nat Cell Biol. 2007 Dec;9(12):1436-41
references: 17982445
references: Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):1100-3
references: 19423866
references: Science. 2007 Dec 21;318(5858):1917-20
references: 18029452
references: Epigenetics. 2011 Jan;6(1):63-75
references: 20861676
references: Nature. 2007 Jul 19;448(7151):313-7
references: 17554338
references: Nature. 2009 Aug 27;460(7259):1149-53
references: 19668189
references: Nat Cell Biol. 2011 May;13(5):541-9
references: 21499256
references: Nature. 2010 Mar 11;464(7286):292-6
references: 20164838
references: Nature. 2008 Jan 10;451(7175):141-6
references: 18157115
references: Stem Cells. 2004;22(7):1168-80
references: 15579637
references: Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17119-24
references: 16284252
references: FEBS Lett. 2010 Sep 10;584(17):3812-8
references: 20655916
references: Cell. 2006 Aug 25;126(4):663-76
references: 16904174
references: Blood. 2008 May 1;111(9):4446-55
references: 18239083
references: Nat Biotechnol. 2007 Oct;25(10):1177-81
references: 17724450
references: Science. 2000 Apr 28;288(5466):665-9
references: 10784448
references: Science. 2007 Dec 21;318(5858):1920-3
references: 18063756
references: Science. 2008 Aug 29;321(5893):1218-21
references: 18669821
references: Nature. 2009 Aug 27;460(7259):1140-4
references: 19668186
references: Nature. 2007 Jul 19;448(7151):318-24
references: 17554336
references: Cell Stem Cell. 2009 Jul 2;5(1):97-110
references: 19540188
references: Reprod Fertil Dev. 2005;17(1-2):85-96
references: 15745634
references: J Biol Chem. 2008 Nov 14;283(46):31601-7
references: 18782754
references: FASEB J. 2009 Dec;23(12):4168-80
references: 19703934
references: Proc Natl Acad Sci U S A. 2009 Jan 20;106(3):808-13
references: 19139414
references: Nature. 2009 Aug 27;460(7259):1132-5
references: 19668191
references: J Cell Sci. 2009 Sep 1;122(Pt 17):3169-79
references: 19671662
references: Cold Spring Harb Symp Quant Biol. 2008;73:127-35
references: 19028986
references: Cell Physiol Biochem. 2009;24(1-2):73-86
references: 19590195
references: Science. 1985 Nov 15;230(4727):758-66
references: 2414846
references: PLoS One. 2011 Feb 28;6(2):e17128
references: 21386890
references: Annu Rev Genomics Hum Genet. 2009;10:45-61
references: 19405848
references: Int J Hematol. 2010 Apr;91(3):384-91
references: 20169427
references: Nat Med. 2007 Jun;13(6):742-7
references: 17486088
references: Cloning. 1999;1(2):119-25
references: 16218837
references: Cell. 2003 May 30;113(5):631-42
references: 12787504
references: Clin Genet. 2008 Feb;73(2):103-12
references: 18005359
references: J Clin Invest. 2010 Jan;120(1):51-9
references: 20051636
references: Stem Cells. 2009 Oct;27(10):2427-34
references: 19658190
references: Science. 2008 Dec 19;322(5909):1811-5
references: 19095934
references: Nature. 2011 Mar 3;471(7336):68-73
references: 21289626
references: Cell Stem Cell. 2009 Feb 6;4(2):141-54
references: 19200803
references: Cell Death Differ. 2011 May;18(5):745-53
references: 21311564
references: Nature. 2009 Aug 27;460(7259):1136-9
references: 19668188
references: FASEB J. 2010 Aug;24(8):2702-15
references: 20354136
references: Nat Genet. 2000 Apr;24(4):372-6
references: 10742100
references: Cell. 2007 Nov 30;131(5):861-72
references: 18035408
references: Nature. 2011 Mar 3;471(7336):58-62
references: 21368824
references: Cell Stem Cell. 2011 Jan 7;8(1):106-18
references: 21211785
references: Nature. 1999 May 27;399(6734):316-7
references: 10360570
references: Nature. 2010 Sep 16;467(7313):285-90
references: 20644535
references: Curr Opin Genet Dev. 2010 Apr;20(2):190-6
references: 20176474
references: Curr Opin Organ Transplant. 2010 Feb;15(1):61-7
references: 19855280
references: Nature. 2011 Mar 3;471(7336):63-7
references: 21368825